Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Real-world comparison of Brivudine vs Valaciclovir for herpes zoster
ChiCTR2600129047Phase 4Not yet recruiting
- Sponsor
- Dalian Dermatology Hospital
- Start
- Jul 2026
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of brivudine and valaciclovir in herpes zoster (HZ) (2 arms), sponsored by Dalian Dermatology Hospital. Primary endpoint: Time to no new herpes lesions. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
brivudinevalaciclovir
03
Conditions
herpes zoster (HZ)
Beyond the preview
Go deeper on ChiCTR2600129047.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600129047.